| Fear of movement and associated factors among adults with symptomatic knee osteoarthritis AH Gunn, TA Schwartz, LS Arbeeva, LF Callahan, Y Golightly, A Goode, ... Arthritis care & research 69 (12), 1826-1833, 2017 | 84 | 2017 |
| Recurrent laryngeal nerve injury after thyroid surgery: an analysis of 11,370 patients A Gunn, T Oyekunle, M Stang, H Kazaure, R Scheri Journal of Surgical Research 255, 42-49, 2020 | 69 | 2020 |
| The emergency department as an opportunity for naloxone distribution AH Gunn, ZPW Smothers, N Schramm-Sapyta, CE Freiermuth, ... Western Journal of Emergency Medicine 19 (6), 1036, 2018 | 55 | 2018 |
| Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model R Young, T Bekele, A Gunn, N Chapman, V Chowdhary, K Corrigan, ... Gates open research 2, 2018 | 51* | 2018 |
| Ovarian tissue transport to expand access to fertility preservation: from animals to clinical practice FE Duncan, M Zelinski, AH Gunn, JE Pahnke, CL O’Neill, N Songsasen, ... Reproduction 152 (6), R201-R210, 2016 | 48 | 2016 |
| Physical therapy vs. internet-based exercise training (PATH-IN) for patients with knee osteoarthritis: study protocol of a randomized controlled trial QI Williams, AH Gunn, JE Beaulieu, BC Benas, B Buley, LF Callahan, ... BMC musculoskeletal disorders 16, 1-12, 2015 | 35 | 2015 |
| Pediatric and teen ovarian tissue removed for cryopreservation contains follicles irrespective of age, disease diagnosis, treatment history, and specimen processing methods FE Duncan, ME Pavone, AH Gunn, S Badawy, C Gracia, JP Ginsberg, ... Journal of adolescent and young adult oncology 4 (4), 174-183, 2015 | 31 | 2015 |
| Funding global health product R&D: the Portfolio-To-Impact Model (P2I), a new tool for modelling the impact of different research portfolios RF Terry, G Yamey, R Miyazaki-Krause, A Gunn, JC Reeder Gates Open Research 2, 2018 | 23 | 2018 |
| Pain coping skills training for African Americans with osteoarthritis (STAART): study protocol of a randomized controlled trial LA Schrubbe, SG Ravyts, BC Benas, LC Campbell, CW Cené, ... BMC musculoskeletal disorders 17, 1-12, 2016 | 20 | 2016 |
| Patient-reported outcomes following total thyroidectomy for Graves' disease AH Gunn, N Frisco, SM Thomas, MT Stang, RP Scheri, HS Kazaure Thyroid 32 (1), 54-64, 2022 | 9 | 2022 |
| Navigating the high costs of cancer care: opportunities for patient engagement AH Gunn, C Sorenson, RA Greenup Future Oncology 17 (28), 3729-3742, 2021 | 7 | 2021 |
| Guideline adherence and practice patterns in the management of medullary thyroid cancer NA Frisco, AH Gunn, F Wang, MT Stang, HS Kazaure, RP Scheri Journal of Surgical Research 281, 214-222, 2023 | 6 | 2023 |
| Analysis of the health product pipeline for poverty-related and neglected diseases using the Portfolio-to-Impact (P2I) modeling tool S Bandara, N Chapman, V Chowdhary, A Doubell, A Hynen, ... F1000Research 9, 2020 | 6 | 2020 |
| Running the numbers: county level dynamics of heroin mortality in North Carolina AH Gunn, B Bartlett, G Feng, M Gayed, K Kanter, E Onuoha, M Thornton, ... North Carolina medical journal 79 (3), 195-200, 2018 | 6 | 2018 |
| Medullary thyroid cancer with RET V804M mutation: more indolent than expected? NA Frisco, AH Gunn, SM Thomas, MT Stang, RP Scheri, HS Kazaure Surgery 173 (1), 260-267, 2023 | 3 | 2023 |
| Tumor marker response to SARS‐CoV‐2 infection among patients with cancer AH Gunn, C Tashie, S Wolf, JD Troy, Y Zafar Cancer Medicine 11 (14), 2865-2872, 2022 | 3 | 2022 |
| Pipeline analysis of a vaccine candidate portfolio for diseases of poverty using the Portfolio-To-Impact modelling tool A Gunn, S Bandara, G Yamey, H Depraetere, S Houard, NK Viebig, ... F1000Research 8, 2019 | 3 | 2019 |
| Costs of care and financial hardship among patients with heart failure AH Gunn, HJ Warraich, RJ Mentz American Heart Journal 269, 94-107, 2024 | 1 | 2024 |
| Assessing the use of low value oncology care following the release of Choosing Wisely guidelines. A Gunn, M Sarver, SJ Kaplan, Y Zafar, RA Greenup Journal of Clinical Oncology 39 (15_suppl), e18861-e18861, 2021 | 1 | 2021 |
| Novel cardiovascular therapeutics and the risk of financial toxicity AH Gunn, A Pendyal Nature Reviews Cardiology, 1-2, 2024 | | 2024 |
